We invite you to participate in this learning lab if you are a psychiatric pharmacist who is interested in developing the skills necessary to perform the AIMS assessment and treating patients with tardive dyskinesia.
Session Summary
Join us for an engaging 90-minute learning lab at the AAPP Annual Meeting in Salt Lake City on April 28 or 29, 2025! This program is designed to enhance skills for assessing and treating patients with tardive dyskinesia (TD). Learners can register for one of four available learning lab sessions and up to 60 people can participate in each lab:
Monday, April 28 1:00-2:30 PM MST
Monday, April 28 3:00-4:30 PM MST
Tuesday, April 29 1:00-2:30 PM MST
Tuesday, April 29 3:00-4:30 PM MST
Prior to attending, participants will complete approximately one hour of pre-work that consists of watching three videos. The intent of the pre-work is to build a foundational understanding of TD and the Abnormal Involuntary Movement Scale (AIMS), ensuring readiness for an immersive, interactive experience.
Each live 90-minute session begins with an introduction, setting the stage for participants to gain targeted skills across three interactive stations. Expert facilitators will provide real-time feedback at each station as learners rotate between activities focused on different aspects of TD assessment and management. Participants will practice scoring facial and oral movements on the AIMS using an actor and guided by a facilitator to ensure accuracy. Learners will further refine their AIMS assessment skills by scoring extremity and truncal movements. Finally, participants will apply their knowledge to clinical patient cases by selecting appropriate treatment options. A facilitator will discuss considerations for selection of a vesicular monoamine transporter type 2 (VMAT2 inhibitor) as well as other treatment recommendations, highlighting patient-specific factors and using the IMPACT-TD tool to identify how TD impacts patients and when treatment is most beneficial.
By the end of this program, learners will feel confident in performing the AIMS assessment and ensuring appropriate TD management for patients. Join this hands-on lab to enhance your skills and make a meaningful impact on TD assessment and treatment!
Course Requirements
You will proceed through the following steps to satisfactorily complete this course:
Sign in (or create a FREE account).
Register for this course.
Complete the pre-test before starting the activity.
Review the full content of the activity and reflect upon its teachings.
Complete the post-test at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
If necessary, complete the post-test retest no later than the closing activity date.
Receive a passing grade (as determined by a panel of experts within 4 weeks following the closing date).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Your ACPE credit will be submitted directly to CPE Monitor within 48 hours of successful completion of the exam and of the evaluation form if you have provided the relevant information in your profile.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended,
or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat
or FoxIt
An adequate device and Internet connection:
Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent);
Memory: 4 GB;
Storage: 5 GB available;
Internet speed: 4.0 Mbps (up/down)
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Faculty Information
Steven C. Stoner, PharmD, BCPP, FAAPP; Learning Lab Chair Austin Campbell, PharmD, BCPP, FAAPP; Learning Lab Facilitator Cynthia A. Gutierrez, PharmD, MS, BCPP, FAAPP; Learning Lab Facilitator Mark E. Schneiderhan, PharmD, BCPP; Learning Lab Facilitator
Steven C. Stoner, PharmD, BCPP, FAAPP; Learning Lab Chair
Associate Dean for Student Affairs and Clinical Professor, UMKC School of Pharmacy
Dr. Stoner received his Doctor of Pharmacy degree from the University of Nebraska College of Pharmacy in 1994. He has been with UMKC since 1996 following post-doctoral completion of an ASHP Accredited Psychiatric Pharmacy Practice & Administration Residency and a Psychiatric Pharmacy Fellowship at Western Missouri Mental Health Center. In 1997 he was awarded an NCDEU-NIMH Young Investigator Award and in 2001 the CPNP AstraZeneca Clinical Pharmacy Practice Award. Dr. Stoner has been the recipient of teaching and preceptor of the year awards while at UMKC with both the School of Pharmacy and School of Dentistry. Dr. Stoner served as the director of an ASHP accredited psychiatric Pharmacy Practice residency program for 10 years (1998-2008) at the Northwest Missouri Psychiatric Rehabilitation Center in St. Joseph, Missouri. In 2006, he completed the American Association of Colleges of Pharmacy Academic (AACP) Leadership Fellows Program. Dr. Stoner has been a member of AAPP since 1997 and has served on numerous committees, including terms on the Board of Directors as Member-at-Large and President (2010-2011). Dr. Stoner has also served as a member of the Board of Directors for the AAPP Foundation. Dr. Stoner is also a member of the American Association of Colleges of Pharmacy and has served on several committees as well as serving on the AACP Board of Directors (2016-2019), as the Chair of the Council of Sections (2017-2018), and the Chair of the Pharmacy Practice Section (2014-2015). Dr. Stoner was also the 2024 recipient of the Anne Marie Liles Distinguished Service Award from AACP. He is currently a Clinical Professor and the Associate Dean for Student Affairs, while previously serving as the Department Chair of the Division of Pharmacy Practice and Administration at the UMKC School of Pharmacy.
Clinical Associate Professor, University of Missouri – Kansas City School of Pharmacy at MU; Adjunct Assistant Professor, University of Missouri School of Medicine
Dr. Austin Campbell, PharmD, BCPP, FAAPP, is a Clinical Associate Professor at the University of Missouri–Kansas City School of Pharmacy at MU and an adjunct assistant professor with the University of Missouri Medical School. He currently practices as a psychiatric ambulatory care pharmacist in the internal medicine clinic. Dr. Campbell completed a PGY-1 residency at the Kansas City VA Medical Center, followed by a PGY-2 specialty residency in psychiatry at the Center for Behavioral Medicine in Kansas City, before obtaining board certification in psychiatric pharmacy (BCPP). Prior to his current academic appointment, he served as the acute inpatient psychiatric pharmacist for adults and pediatrics at University of Missouri Health Care for more than 11 years. A dedicated educator and leader in psychiatric pharmacy, Dr. Campbell has received multiple awards for his commitment to training students, residents, and fellows. Recognized throughout Missouri for his outreach and educational efforts in psychopharmacology, he collaborates with organizations such as the National Alliance on Mental Illness (NAMI), Crisis Intervention Team (CIT), the Missouri Department of Mental Health, Project ECHO, and the Missouri Center for Excellence in Child Well-Being. In 2025, he was selected as part of the inaugural class of Fellows of the American Association of Psychiatric Pharmacists (FAAPP), acknowledging his significant contributions to both the organization and the field of psychiatric pharmacy.
Cynthia A. Gutierrez, PharmD, MS, BCPP, FAAPP; Learning Lab Facilitator
Clinical Pharmacist Practitioner, Psychiatry, South Texas Veterans Health Care System
Cindy Gutierrez graduated from The University of Texas College of Pharmacy with her Doctor of Pharmacy degree in 2001, and a Master of Science in Pharmacy in conjunction with a Psychiatric Pharmacy Practice Residency in 2003. Her residency training through UT was based largely at the San Antonio State Hospital. Dr. Gutierrez has worked at the South Texas Veterans Health Care System as a Clinical Pharmacist Practitioner in Psychiatry for over 20 years, focusing on the treatment of those living with serious mental illness. She served as the initial Residency Program Director for the VA’s UT-affiliated PGY2 Psychiatric Pharmacy Residency for 10 years, starting in 2004. Most recently she served as President of the American Association of Psychiatric Pharmacists, from 2022 to 2023. She maintains an adjunct faculty appointment with the UT College of Pharmacy, serving as a lecturer and preceptor.
Mark Schneiderhan, PharmD, BCPP; Learning Lab Facilitator
Associate Professor, University of Minnesota
Dr. Schneiderhan is an Associate Professor in the Department of Pharmacy Practice and Pharmaceutical Sciences at the University of Minnesota (UMN), College of Pharmacy since 2009. His primary roles at the college include being a course co-director for our neurological/psychiatric didactic content, as well as other mental health related didactic teaching. He has been a college of pharmacy faculty and preceptor for pharmacy students since 2005. Dr. Schneiderhan currently precepts both APPE and IPPE pharmacy students. His major research areas of focus include: 1) Measuring clinical outcomes of pharmacists providing comprehensive medication management (CMM) for people with mental illness and related disabilities; 2) The prevention and management of antipsychotic and other psychotropic agent-related adverse drug reactions (e.g., metabolic syndrome and movement disorders); and 3) The clinical application of pharmacogenetic (PGx) effects on drug metabolism and the impact on pharmacotherapy of mental illnesses. Dr. Schneiderhan's practice and APPE/IPPE experiential site, The Human Development Center (HDC), is a private, non-profit, community mental health center. His primary role is to provide in-person Comprehensive Medication Management (CMM) services, prescribe non-controlled psychiatric medications under HDC’s collaborative practice agreement, coordinate care with external providers, and provide pharmacogenetic consultation services.
Learning Objectives
Choose appropriate pharmacologic treatment strategies for patients with tardive dyskinesia based on patient-specific factors.
Demonstrate proficiency in conducting and scoring the Abnormal Involuntary Movement Scale (AIMS) assessment.
Apply facilitator feedback to improve clinical assessment and treatment approaches for tardive dyskinesia.
Continuing Education Credit and Disclosures
Activity Dates:04/28/2025 - 04/29/2025 ACPE Contact Hours: 1.5 ACPE Number: 0284-0000-25-024-L01-P (Application) Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
Grant Support
This activity is supported by educational grant from Neurocrine Biosciences, Inc.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.